RILCAVO Trademark

Trademark Overview

On Tuesday, July 22, 2014, a trademark application was filed for RILCAVO with the United States Patent and Trademark Office. The USPTO has given the RILCAVO trademark a serial number of 86344643. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 23, 2022. This trademark is owned by AstraZeneca AB. The RILCAVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, inflammation, infection, gastrointestinal diseases and disorders, and nervous system diseases and disorders
rilcavo

General Information

Serial Number86344643
Word MarkRILCAVO
Filing DateTuesday, July 22, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 23, 2022
Registration Number4911909
Registration DateTuesday, March 8, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 12, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, inflammation, infection, gastrointestinal diseases and disorders, and nervous system diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Friday, September 23, 2022CANCELLED SEC. 8 (6-YR)
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 8, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 8, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, January 12, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, November 20, 2015NOTICE OF ALLOWANCE CANCELLED
Tuesday, January 12, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 16, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 16, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 20, 2015TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, July 7, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 12, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 12, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 22, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 3, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 23, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 19, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 19, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 19, 2015ASSIGNED TO LIE
Tuesday, March 10, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 26, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 26, 2014NON-FINAL ACTION E-MAILED
Friday, September 26, 2014NON-FINAL ACTION WRITTEN
Thursday, September 25, 2014ASSIGNED TO EXAMINER
Wednesday, July 30, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 25, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

rilcavo diseases disorders substances preparations pharmaceutical infection gastrointestinal system nervous inflammation